Q32 Bio Inc.
General ticker "QTTB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $47.2M (TTM average)
Q32 Bio Inc. follows the US Stock Market performance with the rate: 38.9%.
Estimated limits based on current volatility of 8.3%: low 12.53$, high 13.98$
Factors to consider:
- Total employees count: 24 as of 2025
- Top business risk factors: Inability to achieve profitability, Inability to raise capital, Product development failure, Regulatory and compliance, Limited operating history
- Current price 120.4% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.03$, 5.84$]
- 2026-12-31 to 2027-12-31 estimated range: [1.97$, 5.46$]
Financial Metrics affecting the QTTB estimates:
- Positive: with PPE of 2.3 at the end of fiscal year the price was low
- Negative: negative Operating cash flow
- Positive: Operating profit margin, % of 31.45 > 18.40
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 68.01 > 64.23
Short-term QTTB quotes
Long-term QTTB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $53.74MM |
| Operating Expenses | $48.26MM | $66.10MM | $36.84MM |
| Operating Income | $-48.26MM | $-66.10MM | $16.90MM |
| Non-Operating Income | $-5.17MM | $20.02MM | $12.92MM |
| R&D Expense | $31.73MM | $48.14MM | $19.16MM |
| Income(Loss) | $-53.42MM | $-46.09MM | $29.82MM |
| Taxes | $0.32MM | $0.02MM | $0.00MM |
| Other Income(Loss) | $0.00MM | $-1.62MM | $0.00MM |
| Net Income(Loss)* | $-53.74MM | $-47.73MM | $29.82MM |
| Stockholders Equity | $72.99MM | $5.67MM | $42.01MM |
| Assets | $84.56MM | $92.33MM | $61.78MM |
| Operating Cash Flow | $-18.68MM | $-67.72MM | $-33.54MM |
| Capital expenditure | $0.01MM | $0.07MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $19.93MM | $7.00MM |
| Financing Cash Flow | $0.41MM | $95.14MM | $-3.12MM |
| Earnings Per Share** | $-16.70 | $-3.91 | $2.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.